Tau oligomers mediate α-synuclein toxicity and can be targeted by immunotherapy
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tau oligomers mediate α-synuclein toxicity and can be targeted by immunotherapy
Authors
Keywords
Tau, Immunotherapy, Oligomers, α-synuclein, Synucleinopathies, Neurodegeneration
Journal
Molecular Neurodegeneration
Volume 13, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-03-15
DOI
10.1186/s13024-018-0245-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Alzheimer's disease pathology in synucleinopathies
- (2017) Johannes Attems LANCET NEUROLOGY
- Drugs in Clinical Trials for Alzheimer's Disease: The Major Trends
- (2017) Sergey O. Bachurin et al. MEDICINAL RESEARCH REVIEWS
- Differential effects of immunotherapy with antibodies targeting α-synuclein oligomers and fibrils in a transgenic model of synucleinopathy
- (2017) Omar El-Agnaf et al. NEUROBIOLOGY OF DISEASE
- The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease
- (2016) Jeff Sevigny et al. NATURE
- Caspase-2 cleavage of tau reversibly impairs memory
- (2016) Xiaohui Zhao et al. NATURE MEDICINE
- Specific Targeting of Tau Oligomers in Htau Mice Prevents Cognitive Impairment and Tau Toxicity Following Injection with Brain-Derived Tau Oligomeric Seeds
- (2016) Diana L. Castillo-Carranza et al. JOURNAL OF ALZHEIMERS DISEASE
- Pathological Interface Between Oligomeric Alpha-Synuclein and Tau in Synucleinopathies
- (2015) Urmi Sengupta et al. BIOLOGICAL PSYCHIATRY
- Direct visualization of alpha-synuclein oligomers reveals previously undetected pathology in Parkinson’s disease brain
- (2015) Rosalind F. Roberts et al. BRAIN
- Tau Immunotherapy Modulates Both Pathological Tau and Upstream Amyloid Pathology in an Alzheimer's Disease Mouse Model
- (2015) D. L. Castillo-Carranza et al. JOURNAL OF NEUROSCIENCE
- Passive Immunization with Tau Oligomer Monoclonal Antibody Reverses Tauopathy Phenotypes without Affecting Hyperphosphorylated Neurofibrillary Tangles
- (2014) D. L. Castillo-Carranza et al. JOURNAL OF NEUROSCIENCE
- Amyloid-β and Tau
- (2014) George S. Bloom JAMA Neurology
- Distinct α-Synuclein Strains Differentially Promote Tau Inclusions in Neurons
- (2013) Jing L. Guo et al. CELL
- Alpha-synuclein interferes with cAMP/PKA-dependent upregulation of dopamine β-hydroxylase and is associated with abnormal adaptive responses to immobilization stress
- (2013) Sasuk Kim et al. EXPERIMENTAL NEUROLOGY
- Non-motor parkinsonian pathology in aging A53T α-Synuclein mice is associated with progressive synucleinopathy and altered enzymatic function
- (2013) Kaitlin F. Farrell et al. JOURNAL OF NEUROCHEMISTRY
- Age-Dependent Effects of A53T Alpha-Synuclein on Behavior and Dopaminergic Function
- (2013) Adam W. Oaks et al. PLoS One
- Behavioral Characterization of A53T Mice Reveals Early and Late Stage Deficits Related to Parkinson’s Disease
- (2013) Katrina L. Paumier et al. PLoS One
- What is the pathological significance of tau oligomers?
- (2012) Catherine M. Cowan et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Exosomal cell-to-cell transmission of alpha synuclein oligomers
- (2012) Karin M Danzer et al. Molecular Neurodegeneration
- Synergistic influence of phosphorylation and metal ions on tau oligomer formation and coaggregation with α-synuclein at the single molecule level
- (2012) Georg Nübling et al. Molecular Neurodegeneration
- Tau acts as an independent genetic risk factor in pathologically proven PD
- (2012) Gavin Charlesworth et al. NEUROBIOLOGY OF AGING
- MAPT H1 haplotype is associated with enhanced α-synuclein deposition in dementia with Lewy bodies
- (2012) Martí Colom-Cadena et al. NEUROBIOLOGY OF AGING
- Tau Accumulation Causes Mitochondrial Distribution Deficits in Neurons in a Mouse Model of Tauopathy and in Human Alzheimer's Disease Brain
- (2011) Katherine J. Kopeikina et al. AMERICAN JOURNAL OF PATHOLOGY
- Region-specific tauopathy and synucleinopathy in brain of the alpha-synuclein overexpressing mouse model of Parkinson's disease
- (2011) Tiffany Kaul et al. BMC NEUROSCIENCE
- Hyperphosphorylated Tau in an α-synuclein-overexpressing transgenic model of Parkinson’s disease
- (2011) Thomas Haggerty et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- E46K Human α-Synuclein Transgenic Mice Develop Lewy-like and Tau Pathology Associated with Age-dependent, Detrimental Motor Impairment
- (2011) Kristel L. Emmer et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- -Syn Suppression Reverses Synaptic and Memory Defects in a Mouse Model of Dementia with Lewy Bodies
- (2011) Y. Lim et al. JOURNAL OF NEUROSCIENCE
- Induction of Intracellular Tau Aggregation Is Promoted by -Synuclein Seeds and Provides Novel Insights into the Hyperphosphorylation of Tau
- (2011) E. A. Waxman et al. JOURNAL OF NEUROSCIENCE
- Tauopathic Changes in the Striatum of A53T α-Synuclein Mutant Mouse Model of Parkinson's Disease
- (2011) Jonathan Wills et al. PLoS One
- Interaction between -Synuclein and Other Proteins in Neurodegenerative Disorders
- (2011) Kurt A. Jellinger TheScientificWorldJOURNAL
- Preparation and Characterization of Neurotoxic Tau Oligomers
- (2010) Cristian A. Lasagna-Reeves et al. BIOCHEMISTRY
- Elevated tauopathy and alpha-synuclein pathology in postmortem Parkinson's disease brains with and without dementia
- (2010) Jonathan Wills et al. EXPERIMENTAL NEUROLOGY
- Distinct Region-Specific -Synuclein Oligomers in A53T Transgenic Mice: Implications for Neurodegeneration
- (2010) E. Tsika et al. JOURNAL OF NEUROSCIENCE
- Staging of α-synuclein in the olfactory bulb in a model of Parkinson's disease: Cell types involved
- (2010) Isabel Ubeda-Bañon et al. MOVEMENT DISORDERS
- α-Synuclein contributes to GSK-3β-catalyzed Tau phosphorylation in Parkinson’s disease models
- (2009) Tetyana Duka et al. FASEB JOURNAL
- Genome-wide association study reveals genetic risk underlying Parkinson's disease
- (2009) Javier Simón-Sánchez et al. NATURE GENETICS
- Selective noradrenergic vulnerability in alpha-synuclein transgenic mice
- (2009) Evangelos Sotiriou et al. NEUROBIOLOGY OF AGING
- A critical reappraisal of current staging of Lewy-related pathology in human brain
- (2008) Kurt A. Jellinger ACTA NEUROPATHOLOGICA
- Applicability of current staging/categorization of α-synuclein pathology and their clinical relevance
- (2008) Laura Parkkinen et al. ACTA NEUROPATHOLOGICA
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started